Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Davidson

Showing results (21-30 of 358) with videos related to

Pageof 36
Sort By:
Endocrinology and Metabolism Clinics of North America|November 30, 2014
Combination therapy with statins: who benefits?Amita Singh, Michael Davidson
Dialogues in Clinical Neuroscience|October 15, 2019
Is dementia a preventable disease ?Michael Davidson, Florence Thibaut
Molecular Psychiatry|July 10, 2021
Identifying an elusive target with the help of an unproven techniqueMark Weiser, Michael Davidson
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 22, 2012
Placebo, a historical perspectiveEfrat Czerniak, Michael Davidson
Expert Opinion on Biological Therapy|July 14, 2016
Immunotherapy for oesophagogastric cancerMichael Davidson, Ian Chau
Expert Review of Anticancer Therapy|February 13, 2018
Multimodality treatment of operable gastric and oesophageal adenocarcinoma: evaluating neoadjuvant, adjuvant and perioperative approachesMichael Davidson, Ian Chau
Translational Gastroenterology and Hepatology|February 1, 2017
Variations in outcome for advanced gastric cancer between Japanese and Western patients: a subgroup analysis of the RAINBOW trialMichael Davidson, Ian Chau
The Lancet. Oncology|October 14, 2016
Colorectal cancer trial endpoints: time for dynamic thinking?Michael Davidson, Ian Chau
The International Journal of Neuropsychopharmacology|July 12, 2013
Considerations in psychotropic treatments in dementia--can polypharmacy be avoided?Ramit Ravona-Springer, Michael Davidson
Schizophrenia Bulletin|November 6, 2023
Targeted Treatment of Schizophrenia Symptoms as They Manifest, or Continuous Treatment to Reduce the Risk of Psychosis RecurrenceMichael Davidson, William T Carpenter
Pageof 36

Showing results (21-30 of 358) with videos related to

Sort By:
Pageof 36
Endocrinology and Metabolism Clinics of North America|November 30, 2014
Combination therapy with statins: who benefits?Amita Singh, Michael Davidson
Dialogues in Clinical Neuroscience|October 15, 2019
Is dementia a preventable disease ?Michael Davidson, Florence Thibaut
Molecular Psychiatry|July 10, 2021
Identifying an elusive target with the help of an unproven techniqueMark Weiser, Michael Davidson
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 22, 2012
Placebo, a historical perspectiveEfrat Czerniak, Michael Davidson
Expert Opinion on Biological Therapy|July 14, 2016
Immunotherapy for oesophagogastric cancerMichael Davidson, Ian Chau
Expert Review of Anticancer Therapy|February 13, 2018
Multimodality treatment of operable gastric and oesophageal adenocarcinoma: evaluating neoadjuvant, adjuvant and perioperative approachesMichael Davidson, Ian Chau
Translational Gastroenterology and Hepatology|February 1, 2017
Variations in outcome for advanced gastric cancer between Japanese and Western patients: a subgroup analysis of the RAINBOW trialMichael Davidson, Ian Chau
The Lancet. Oncology|October 14, 2016
Colorectal cancer trial endpoints: time for dynamic thinking?Michael Davidson, Ian Chau
The International Journal of Neuropsychopharmacology|July 12, 2013
Considerations in psychotropic treatments in dementia--can polypharmacy be avoided?Ramit Ravona-Springer, Michael Davidson
Schizophrenia Bulletin|November 6, 2023
Targeted Treatment of Schizophrenia Symptoms as They Manifest, or Continuous Treatment to Reduce the Risk of Psychosis RecurrenceMichael Davidson, William T Carpenter
Pageof 36